MedTravest II ApS: Financial statements 2023
CVR: 42368032
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MedTravest II ApS (CVR 42368032) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -18,750 and a net result of DKK -18,750 compared with DKK -37,952 the year before. Equity in the 2023 report amounted to DKK 7,667,219. The solvency ratio was 99.3%.
- Gross Profit
- DKK -18,750
- Profit/Loss
- DKK -18,750
- Equity
- DKK 7,667,219
- Total Assets
- DKK 7,719,146
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 21, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MedTravest II ApS.
As of December 21, 2023, Peter Juul Kristensen has joined the board of directors of MedTravest II ApS.
As of December 21, 2023, Mark Lund Andersen has joined the board of directors of MedTravest II ApS.
As of December 21, 2023, Tore Jesper Andersen has joined the board of directors of MedTravest II ApS.
As of December 21, 2023, Peter Juul Kristensen is registered as director of MedTravest II ApS.
As of December 21, 2023, Bernt Skov Jensen has stepped down as director of MedTravest II ApS.
MedTravest II ApS has published its annual report for 2022. The net result was DKK -37,952.
About MedTravest II ApS
MedTravest II ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named ApS STAKE nr. 6158. The management consists of Jens Strathe. The board consists of Mark Lund Andersen (chair), Jens Strathe and Tore Jesper Andersen. The company's owners include STRATHE INVEST ApS, JUUL KRISTENSEN HOLDING ApS and MedTravest A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -186,772 and a net result of DKK -186,772 compared with DKK -23,546 the year before. Equity in the 2025 report amounted to DKK 7,565,001.